Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	69.55	34.27	15.75	10.69	9.24
Short-Term Investments	0	0	54.6	54.78	52.78
Cash & Cash Equivalents	69.55	34.27	70.35	65.47	62.02
Cash Growth	102.92%	-51.28%	7.46%	5.57%	-31.33%
Receivables	4.42	0.49	0	0	0
Inventory	1.02	0	0	0	0
Other Current Assets	2.55	4.36	3.97	2.18	2.97
Total Current Assets	77.53	39.12	74.33	67.65	64.98
Property, Plant & Equipment	3.62	5.33	5.5	4.94	2.2
Other Long-Term Assets	0.45	0.28	0.3	1.57	1.24
Total Long-Term Assets	4.07	5.61	5.8	6.5	3.44
Total Assets	81.6	44.72	80.13	74.15	68.42
Accounts Payable	2.46	0.51	0.85	0.35	1.19
Deferred Revenue	0	0	0	0.5	0
Current Debt	0.7	0.3	41.94	35.51	0.13
Other Current Liabilities	13.86	2.66	3.27	3.11	2.04
Total Current Liabilities	17.02	3.46	46.06	39.48	3.35
Long-Term Debt	44.81	1.23	1.47	1.69	0.06
Total Long-Term Liabilities	44.81	1.23	1.47	1.69	0.06
Total Liabilities	61.83	4.69	47.52	41.17	3.41
Total Debt	45.51	1.53	43.41	37.21	0.19
Debt Growth	2882.31%	-96.48%	16.67%	19690.43%	-
Retained Earnings	-230.45	-163.45	-138.97	-103.89	-61.19
Comprehensive Income	0	0	-0.03	0	0.02
Shareholders' Equity	19.76	40.03	32.61	32.99	65.02
Net Cash / Debt	24.04	32.75	26.95	28.26	61.83
Net Cash / Debt Growth	-26.60%	21.53%	-4.67%	-54.29%	-31.54%
Net Cash Per Share	0.53	0.96	1.00	1.13	2.48
Working Capital	60.51	35.66	28.27	28.18	61.63
Book Value Per Share	0.44	1.17	1.21	1.32	2.61

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).